Postoperative Analgesia Using Ganglion Impar Block After Anal Surgery

ConditionPostoperative Pain

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorUniversity of Alexandria

About this trial

The aim of this study is to evaluate the ganglion Impar block in the prevention of postoperative pain after anal surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients undergoing hemorrhoidectomy surgery in Alexandria University hospital.

Disqualifiers

Coagulation effects

Allergy to Bupivacaine

Previous anal surgery

Patient refusal

Trial design

Design model

Parallel

Treatments tested in this trial

Ganglion impar block with Bupivacaine.
Procedure/Surgery
Bupivacaine group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Bupivacaine 0.5% 10ml. Postoperative VAS will be measured each 1 for the first 6 hours then at 9 and 12 hours postoperative.
Ganglion impar block with normal saline
Procedure/Surgery
Saline group; Ganglion Impar will be blocked using G25 Quinqe spinal needle using Normal Saline 10ml Postoperative VAS will be measured each 1 for the first 6 hours then at 9 and 12 hours postoperative.

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: Ganglion impar block with Bupivacaine.Active comparator 1 intervention

Group B: Ganglion impar block with SalinePlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

Postoperative pain

VAS sore 0-10

Time frame

24 hours

Secondary outcomes

First request of pain medications will be measured.

Time in hours

Time frame

24 hours

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Alexandria

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: